学术搜索
科研智能体
- Research Labs
- AI 阅读
- AI 文库
- AMiner 沉思
- AMiner 亮点
学术资源
- AI2000
- 期刊/会议
- 学者库
- 学术API
- 溯源树
- 数据集
知识沉淀
- 学术空间

订阅小程序

旧版功能

立即登录

学术搜索
科研智能体
- Research Labs
- AI 阅读
- AI 文库
- AMiner 沉思
- AMiner 亮点
学术资源
- AI2000
- 期刊/会议
- 学者库
- 学术API
- 溯源树
- 数据集
知识沉淀
- 学术空间

订阅小程序

旧版功能

立即登录

Pretreatment with a Novel Toll-like Receptor 4 Agonist Attenuates Renal Ischemia-Reperfusion Injury | AMiner

Pretreatment with a Novel Toll-like Receptor 4 Agonist Attenuates Renal Ischemia-Reperfusion Injury

Antonio Hernandez,Naeem K. Patil,Maya Brewer,Rachel Delgado,Lauren Himmel,Lauren N. Lopez,Julia K. Bohannon,Allison M. Owen,Edward R. Sherwood,Mark P. de Caestecker

American journal of physiology. Renal physiology（2023）SCI 3区

Vanderbilt Univ

被引用4|浏览39

摘要

Pretreatment with 3-deacyl 6-acyl phosphorylated hexaacyl disaccharide; a novel synthetic Toll-like receptor 4 agonist, preserves kidney function during ischemia-reperfusion injury-induced acute kidney injury.

查看译文

关键词

acute kidney injury,3-deacyl 6-acyl phosphorylated hexaacyl disaccharide,ischemia-reperfusion injury,phosphorylated hexaacyl disaccharide,Toll-like receptor 4 agonist

上传PDF